Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06660537

Effects of Balloon-blowing Exercises in 90/90 Bridge Position With a Ball on Pulmonary Function Among Asthmatic Patients

In asthma, the airways in the respiratory system can experience inflammation and constriction, causing increased difficulty in expelling air during exhalation. This results in disruptions to respiratory parameters, exercise intolerance, and a diminished overall quality of life.Engaging in balloon-blowing exercises while in a 90/90 bridge position with the use of a ball will lead to enhanced pulmonary function and quality of life in individuals with asthma.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Asthma Bronchial Diseases Dyspnea Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Pathological Conditions, Signs and Symptoms Respiration Disorders Respiratory Hypersensitivity Respiratory Tract Diseases Signs and Symptoms Signs and Symptoms, Respiratory

Age range

18 year–59 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Foundation University College of Physical Therapy

Rawalpindi, Punjab Province, 46000, Pakistan

Location status: Recruiting

Location contact

Sana Bashir, PhD*

CONTACT

[email protected]

0321-8529475

About this study

Asthma attacks and labored breathing can cause strain and weakness in the diaphragm, the main muscle supporting breathing, as well as the muscles of core.

The study objective is to determine the effects of balloon-blowing exercises in 90/90 bridge posotion with a ball on pulmonary function and quality of life among asthmatic patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults: aged (18-59 years)
  • Gender: Both male and females
  • Grade1- Grade 4 on Modified MRC dyspnea scale
  • Asthma severity ( level 1 mild intermediate, levell 2 mild persistent)

Exclusion criteria

  • Level 3 and above asthmatics or status asthmatics.
  • Any congenital deformities of chest wall/ Heart/ Lungs.
  • Demonstrated neuromuscular or neurological deficit/ chest wall deformity.
  • Cardiopulmonary diseases including coronary artery disease(CAD), Pulmonary HTN, ------Aortic Stenosis, regurgitation, etc.
  • Any Autoimmune disease with manifestations of Chest wall/ heart/ Lungs.
  • Any recent cardiothoracic or abdominal surgery or sternotomy.
  • Recent history of the blunt chest wall or abdominal trauma.
  • Unstable hemodynamic parameters (arterial pressure >140mmhg systolic and >90mmhg for diastolic).
  • Pregnancy

Treatment and study plan

Balloon-blowing exercises in 90/90 bridge position with a ball.

Procedure

In this group patients will undergo balloon-blowing exercises in the 90/90 bridge position with a ball. In this intervention, patients lie on back with feet against a wall and knee bent at 90 degrees, holding a ball between their knees. While extending one arm overhead and holding a balloon in the other hand, perform a pelvic tilt without lifting their back off the mat. Inhale through the nose, exhale into the balloon for four breaths, then remove the balloon and repeat the sequence four times. The 4-week protocol includes three supervised sessions per week, each supervised by a physiotherapist. Progress will be monitored regularly to evaluate improvements throughout the intervention.

Buteyko breathing exercises management

Procedure

In this group, patients will receive Buteyko breathing exercises, which consist of two main exercises; the control pause and the maximum pause. For control pause, patients exhale, plug the nose, and hold their breath until they feel the urge to breathe, then inhale and breathe normally for 10 seconds. In Maximum pause, patients exhale, plug their nose, and hold their breath as long as possible, aiming for double the control pause time, then inhale and breath normally for 10 seconds. This is a 4-week protocol with three sessions per week. Pre- and post-intervention values will be recorded to assess progress.

Primary outcomes

  1. pulmonary function test

    Time frame: 4 weeks

    Evaluation will be done using Spirometry

  2. Dyspnea

    Time frame: 4 weeks

    Evaluation will be done using mMRC scale

  3. Quality of life of patient

    Time frame: 4 Weeks

    Quality of life will be evaluated by asthma quality of life questionnaire with standardized Activities AQLQ(S)

  4. Oxygen Saturation

    Time frame: 4 Weeks

    Oxygen saturation will be evaluated by pulse oximeter

Study contacts

Contact information is provided by the study sponsor or research team.

Anam Anwar, MS-CPT*

CONTACT

[email protected]

0333-5226687

Sponsors and collaborators

Lead sponsor

Foundation University Islamabad

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Oct 28, 2024
Registry last updated
Oct 28, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.